MAPK3 and myocardial ischemia: Pretreatment with liver ischemic preconditioning renders the heart less susceptible to subsequent severe myocardial ischemia and reperfusion-induced ventricular arrhythmia, which may occur as a consequence of phosphorylation of critical myocardial kinases ERK1/2 and GSK-3β.